Literature DB >> 15620253

Inhibitory effects of bufadienolides on interleukin-6 in MH-60 cells.

Akiko Enomoto1, Mun-Chual Rho, Kanki Komiyama, Masahiko Hayashi.   

Abstract

Derivatives of bufogenin isolated from the skin of the Chinese toad, Bufo bufo gargarizans Cantor ("Ch'an Su"), and several semisynthetic derivatives of 20beta,21beta-epoxy-resibufogenin (13) have been evaluated for interleukin-6 (IL-6) antagonistic activity due to their growth-inhibitory activities on IL-6-dependent MH-60 cells. Among the naturally derived compounds (1-17), 20S,21-epoxy-resibufogenin formate (1) showed potent inhibitory activity on the IL-6-dependent growth of MH-60 cells. Epoxide groups at both the C-14, C-15 and C-20, C-21 positions are required to exhibit this type of activity. Compounds acetylated at the C-16 position (7 and 9-11) showed a loss of activity. An oxo group at the C-3 position (8, 14, and 15) resulted in cytotoxicity for both cell lines. Stereochemistry is important for selectivity on suppression of IL-6 activity. Among the semisynthetic derivatives (18-25) of 13, compound 19, with an acetyl group introduced at the C-3 position in comparison to 13, demonstrated considerable growth inhibition of IL-6-dependent MH-60 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15620253     DOI: 10.1021/np049950e

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  8 in total

Review 1.  Angel of human health: current research updates in toad medicine.

Authors:  Qian Yang; Xuanxuan Zhou; Meng Zhang; Linlin Bi; Shan Miao; Wei Cao; Yanhua Xie; Jiyuan Sun; Haifeng Tang; Ying Li; Qing Miao; Siwang Wang
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

2.  Configurational reassignment and improved preparation of the competitive IL-6 receptor antagonist 20R,21R-epoxyresibufogenin-3-formate.

Authors:  Terrence L Boos; Kejun Cheng; Elisabeth Greiner; Jeffrey R Deschamps; Arthur E Jacobson; Kenner C Rice
Journal:  J Nat Prod       Date:  2012-02-23       Impact factor: 4.050

3.  Novel potential agents for ulcerative colitis by molecular topology: suppression of IL-6 production in Caco-2 and RAW 264.7 cell lines.

Authors:  María Galvez-Llompart; María Del Carmen Recio Iglesias; Jorge Gálvez; Ramón García-Domenech
Journal:  Mol Divers       Date:  2013-06-23       Impact factor: 2.943

4.  Apoptosis of lens epithelial cells induced by cinobufagin in vitro.

Authors:  Guo-Xing Xu; Ting-Ting Wang
Journal:  Int J Ophthalmol       Date:  2010-06-18       Impact factor: 1.779

5.  IL-6 and MYC collaborate in plasma cell tumor formation in mice.

Authors:  Sebastian Rutsch; Vishala T Neppalli; Dong-Mi Shin; Wendy DuBois; Herbert C Morse; Hartmut Goldschmidt; Siegfried Janz
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

6.  Prevention of AMI Induced Ventricular Remodeling: Inhibitory Effects of Heart-Protecting Musk Pill on IL-6 and TNF-Alpha.

Authors:  Wei Cen; Zhiliang Chen; Ning Gu; Ralph Hoppe
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-06       Impact factor: 2.629

7.  New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity.

Authors:  Veronika Talianová; Zdeněk Kejík; Robert Kaplánek; Kateřina Veselá; Nikita Abramenko; Lukáš Lacina; Karolína Strnadová; Barbora Dvořánková; Pavel Martásek; Michal Masařík; Magdalena Houdová Megová; Petr Bušek; Jana Křížová; Lucie Zdražilová; Hana Hansíková; Erik Vlčák; Vlada Filimonenko; Aleksi Šedo; Karel Smetana; Milan Jakubek
Journal:  Pharmaceutics       Date:  2022-08-17       Impact factor: 6.525

8.  The mechanisms of chansu in inducing efficient apoptosis in colon cancer cells.

Authors:  Chun Li; Saeed M Hashimi; Siyu Cao; Albert S Mellick; Wei Duan; David Good; Ming Q Wei
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-30       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.